These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31294646)

  • 21. Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study.
    Potkin SG; Kunovac J; Silverman BL; Simmons A; Jiang Y; DiPetrillo L; McDonnell D
    J Clin Psychiatry; 2020 Mar; 81(2):. PubMed ID: 32141723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia.
    Monahan C; McCoy L; Powell J; Gums JG
    Ann Pharmacother; 2022 Sep; 56(9):1049-1057. PubMed ID: 35040357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hepatic and renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination as a bilayer tablet.
    Sun L; Yagoda S; Du Y; von Moltke L
    Drug Des Devel Ther; 2019; 13():2941-2955. PubMed ID: 31686778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic administration of buprenorphine in combination with samidorphan produces sustained effects in olfactory bulbectomised rats and Wistar-Kyoto rats.
    Burke NN; Li Y; Deaver DR; Finn DP; Roche M; Eyerman DJ; Sanchez C; Kelly JP
    J Psychopharmacol; 2019 Dec; 33(12):1620-1627. PubMed ID: 31512988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects.
    Ersland KM; Myrmel LS; Fjære E; Berge RK; Madsen L; Steen VM; Skrede S
    Int J Neuropsychopharmacol; 2019 May; 22(5):358-369. PubMed ID: 30854556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats.
    Yang CP; Wang YY; Lin SY; Hong YJ; Liao KY; Hsieh SK; Pan PH; Chen CJ; Chen WY
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats.
    Lian J; Deng C
    Pharmacol Biochem Behav; 2020 Apr; 191():172878. PubMed ID: 32112786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota.
    Kao AC; Spitzer S; Anthony DC; Lennox B; Burnet PWJ
    Transl Psychiatry; 2018 Mar; 8(1):66. PubMed ID: 29540664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis.
    Albaugh VL; Judson JG; She P; Lang CH; Maresca KP; Joyal JL; Lynch CJ
    Mol Psychiatry; 2011 May; 16(5):569-81. PubMed ID: 20308992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine-Alone Tablets: Results From a Randomized, Crossover Relative Bioavailability Study.
    Sun L; McDonnell D; Liu J; von Moltke L
    Clin Pharmacol Drug Dev; 2019 May; 8(4):459-466. PubMed ID: 30059196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.
    Kurbanov DB; Currie PJ; Simonson DC; Borsook D; Elman I
    J Psychopharmacol; 2012 Sep; 26(9):1244-51. PubMed ID: 22723540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial.
    Brunette MF; Correll CU; O'Malley SS; McDonnell D; DiPetrillo L; Jiang Y; Simmons A; Silverman BL; Citrome L; Green AI
    J Clin Psychiatry; 2020 Mar; 81(2):. PubMed ID: 32160422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the reinforcing potential of samidorphan and naltrexone by fixed and progressive ratio intravenous self-administration testing in heroin-maintained rats.
    Smith SL; Dean RL; Todtenkopf MS; Heal DJ
    J Psychopharmacol; 2019 Mar; 33(3):383-391. PubMed ID: 30676189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension.
    Kahn RS; Silverman BL; DiPetrillo L; Graham C; Jiang Y; Yin J; Simmons A; Bhupathi V; Yu B; Yagoda S; Hopkinson C; McDonnell D
    Schizophr Res; 2021 Jun; 232():45-53. PubMed ID: 34015555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
    Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
    Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precipitated opioid withdrawal in a patient started on olanzapine/samidorphan.
    Chambers A; Patton J; Wills BK
    Am J Emerg Med; 2024 May; 79():230.e1-230.e2. PubMed ID: 38556414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.
    Citrome L; Holt RI; Walker DJ; Hoffmann VP
    Clin Drug Investig; 2011; 31(7):455-82. PubMed ID: 21495734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A parametric analysis of olanzapine-induced weight gain in female rats.
    Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
    Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effect of Renal Impairment on the Pharmacokinetics of Olanzapine and Samidorphan Given in Combination.
    Sun L; von Moltke L; Rowland Yeo K
    Clin Pharmacokinet; 2021 May; 60(5):637-647. PubMed ID: 33313995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining samidorphan with olanzapine to mitigate weight gain as a side effect in schizophrenia treatment.
    Grywińska WB; Głowacka A
    Postep Psychiatr Neurol; 2023 Sep; 32(3):128-137. PubMed ID: 38034507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.